Collectively, our study underscores the importance of the COX-2-PGE2-MMP-9 axis in KS pathogenesis and suggests that COX-2 inhibitors have tremendous therapeutic potential in KSHV biology. The gene discussed is PTGS2; the disease is Kaposi's sarcoma.